Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA panel gives nod to Merck hep C drug
Bizjournals.com
Thursday, April 28, 2011 - 7:17am
tags:
Merck, hepatitis C, FDA, Boceprevir, advisory panels
SuperGen's CEO Discusses Q1 2011 Results - Earnings Call Transcript
Seeking Alpha
Thursday, April 28, 2011 - 7:15am
tags:
Supergen, earnings
J.&J. May Have More Acquisitions in Mind
NY Times, NY
Thursday, April 28, 2011 - 7:14am
tags:
JNJ, M&A
Eli Lilly says US District Court blocks Cymbalta generics until patent ends in June 2013
Yahoo/AP
Thursday, April 28, 2011 - 7:14am
tags:
patents, Eli Lilly, generics, Cymbalta, antidepressants
Lilly wants to prove next-gen schizophrenia drug has a blockbuster future
Fierce Biotech
Wednesday, April 27, 2011 - 12:18pm
tags:
Eli Lilly, Zyprexa, schizophrenia
J&J CEO: Most product recalls are behind us; with changes, we'll win back public trust, sales
Yahoo/AP
Wednesday, April 27, 2011 - 12:16pm
tags:
William Weldon, Pharma CEOs, JNJ, recalls
Top 10 Biopharma CEO salaries of 2010
Fierce Pharma
Wednesday, April 27, 2011 - 12:08pm
tags:
executive pay
Digesting Synthes May Not Be Easy for Johnson & Johnson
WSJ Online
Wednesday, April 27, 2011 - 12:06pm
tags:
M&A, JNJ, Synthes, Device
Merck Board Approves $5 Billion More in Buybacks
Barron's
Wednesday, April 27, 2011 - 12:04pm
tags:
Merck, stock buyback
Insider Picks: 5 Biotech Stocks Being Snapped Up by Insider Executives
Seeking Alpha
Wednesday, April 27, 2011 - 11:46am
tags:
Complete Genomics, Corcept Therapeutics, Seattle Genetics, Ziopharm, MannKind
Bayer Loses Court Bid To Squelch Yaz Critics
Pharmalot
Wednesday, April 27, 2011 - 11:39am
tags:
Bayer, birth control pill, Yaz, Yasmin
Are You Missing Something Easy at Elan?
Motley Fool
Wednesday, April 27, 2011 - 11:37am
tags:
Elan
GlaxoSmithKline sales drop, outlook brightens
Marketwatch
Wednesday, April 27, 2011 - 11:31am
tags:
earnings, GSK
Inspire's Pink Eye Drug AzaSite Draws Generic Challenge
Motley Fool
Wednesday, April 27, 2011 - 11:31am
tags:
Inspire, generics, Azasite, Merck, pink eye
Regeneron, Glaxo gain in early action
Marketwatch
Wednesday, April 27, 2011 - 11:30am
tags:
Regeneron, GSK, Zaltrap, colorectal cancer
Merck: Earnings Preview
Yahoo/Zacks.com
Wednesday, April 27, 2011 - 11:17am
tags:
Merck, earnings
5 Large Cap Pharmas - Proceed With Caution
Seeking Alpha
Wednesday, April 27, 2011 - 11:16am
tags:
JNJ, Eli Lilly, Merck, Novartis, Sanofi
A Primer on Pacira Pharma
Seeking Alpha
Wednesday, April 27, 2011 - 11:15am
tags:
Pacira, EXPAREL
Earnings Preview: Bristol-Myers reports 1Q results
Yahoo/AP
Wednesday, April 27, 2011 - 11:14am
tags:
earnings, Bristol-Myers Squibb
Merck: FDA Hep C Panel Live Blog
TheStreet.com
Wednesday, April 27, 2011 - 11:11am
tags:
Merck, advisory panels, FDA, hepatitis C, Vertex Pharmaceuticals, Boceprevir

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.